We’re not finding what you’re searching for. Click below to send us an email and our customer support team will help you find what you’re looking for.
BRILINTA is used to lower your chance of having another heart attack or dying from a heart attack or stroke, but BRILINTA (and similar drugs) can cause bleeding that can be serious and sometimes lead to death. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. While you take BRILINTA, you may bruise and bleed more easily and be more likely to have nosebleeds. Bleeding will also take longer than usual to stop.
Other common side effects with BRILINTA include dizziness, nausea, diarrhea, slow heartbeat rate, rash, and allergic reactions including swelling of the face, throat, lips, tongue, hands, or feet.
Brilinta, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with – acute coronary syndromes (ACS) or – a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event. Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years.
Send Your Prescription
No Hidden Fees
Typically Under 7 days
Are you wondering which drugs are most popular on the IsraelPharm website? Maybe you or someone you know is looking for an alternative source for your prescriptions meds? then read on if you’re curious about
Nutrition for seniors is essential for maintaining a good quality of life and goes a long way to staying healthy into old age. There is an old adage that says “you are what you eat”
For kidney month, lets to look at the latest Israel advances made in nephrology. Chronic kidney disease (CKD) is a condition where there is a gradual loss of kidney function over time. When your kidneys
Just a few funnies that you may know and some you may not – tell us what you think …
The latest findings from the New England Journal of Medicine says finasteride is more effective at treating prostate cancer than they initially thought …
